Compugen Ltd (CGEN)

Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress

Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress PR Newswire...

Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026

Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026 PR Newswire HOLON, Israel, June...

Form EFFECT - Notice of Effectiveness

Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development

Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development PR Newswire HOLON, Israel, June 8...

Form F-3 - Registration statement by foreign private issuers

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Compugen Reports First Quarter 2026 Results

Compugen Reports First Quarter 2026 Results PR Newswire HOLON, Israel, May 18, 2026 COM701 MAIA-ovarian trial actively enrolling patients...

Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum

Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum PR Newswire HOLON, Israel, May 12, 2026 HOLON, Israel, May 12, 2026...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 144 - Report of proposed sale of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]